to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
In the last few days, two big names have announced they aren’t going to run for President. So what bearing does that have on the race for the White House in 2012? Here are five ways these non-announcements will have an impact on the race.
Four U.S. Senators yesterday introduced Startup Act 2.0. This Bipartisan legislation, which combines two pieces of legislation that were introduced last year builds upon the original Startup Act and the AGREE Act, highlights four major components to jumpstarting the nation’s economy
As the Kauffman Foundation, the Partnership for a New American Economy and many others have repeatedly shown, immigrants make great entrepreneurs. We know that 40 percent of 2010's Fortune 500 companies were founded by new Americans. Immigrants start firms at rates much higher than natives.
Building and protecting an intellectual property portfolio for your life science startup is important not only for protecting an idea, but also for increasing your company's valuation. Read more for tips on intellectual property protection.
As politicians have continued to debate the pros and cons of the Affordable Care Act, aka "Obamacare," some federal health officials have been working to spread the word about another aspect of healthcare reform: the move to give consumers more access to their own healthcare data.
Even if legal attempts to derail the US healthcare reform bill were successful, it wouldn’t really matter.
A venture capital fund that has helped Ohio companies and created jobs has an unclear future. The Ohio Capital Fund is waiting on new legislation to help it continue. Read more to find out how this state-backed venture program works.
The FDA needs a chief innovation officer to help the agency stay informed about the latest technological advances, says the head of the biotechnology industry's leading trade group. Read more about what he has to say on the FDA and FDA reform.
Medical devices could get to market faster if regulators didn't have to test for both safety and efficacy of new devices. Read more about how the use of post-market studies could bring new therapies to patients more quickly.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.